Cleared Traditional

K120997 - BAROSTAT SOFTWARE OPTION

K120997 is an FDA 510(k) clearance for BAROSTAT SOFTWARE OPTION, manufactured by Crospon, Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code FFX cleared through the Traditional 510(k) pathway after a 147-day FDA review.

K120997 · Crospon, Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
147d
Days
Class 2
Risk

K120997 is an FDA 510(k) clearance for the BAROSTAT SOFTWARE OPTION. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Crospon, Ltd. (Bonita Springs, US). The FDA issued a Cleared decision on August 27, 2012 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Crospon, Ltd. devices

FDA 510(k) Submission Details - K120997

510(k) Number K120997 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2012
Decision Date August 27, 2012
Days to Decision 147 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 131d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FFX Device Classification - Class 2, Special Controls

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 43
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K120997.
ManoScan System
K151086 · Given Imaging , Ltd. · Apr 2016
ENDOFLIP CATHETER
K130906 · Crospon, Ltd. · Jul 2013
PRESSURIZED INFUSION PUMP
K122294 · Mui Scientific · Nov 2012
SOLAR GI
K121014 · Medical Measurement Systems B.V. · Aug 2012
SPHINCTER OF ODDI MANOMETRIC (SOM) SYSTEM
K120524 · Mui Scientific · Jun 2012
INSIGHT, MODEL S980000
K012232 · Sandhill Scientific, Inc. · Jun 2002